alpelisib and t-dm1 for her2-positive metastatic breast cancer
Published 3 years ago • 160 plays • Length 4:48Download video MP4
Download video MP3
Similar videos
-
3:27
alpelisib plus fulvestrant for hormone receptor positive metastatic breast cancer
-
3:58
frontline t-dm1 in her2-positive metastatic breast cancer
-
9:38
role of t-dm1 in her2-positive metastatic breast cancer
-
3:25
new data comparing adjuvant t-dm1 vs trastuzumab for her2 breast cancer
-
4:54
adjuvant t-dm1 for stage i her2 breast cancer
-
7:49
asco: alpelisib plus fulvestrant for pik3ca-mutated breast cancer after failure of cdk4/6 inhibitors
-
10:23
sequencing endocrine treatment in metastatic luminal breast cancer and alpelisib for treatment o...
-
5:14
adding alpelisib for hr /her2- advanced breast cancer in solar-1: adverse event impacts
-
4:26
dr. sara tolaney on adjuvant t-dm1 vs paclitaxel and trastuzumab for stage i her2 breast cancer
-
5:15
case review: t-dm1 for residual her2 breast cancer
-
4:52
emilia trial: t-dm1 in metastatic breast cancer
-
7:01
solar-1 trial in metastatic breast cancer
-
9:02
novel therapies in the management of her2-positive breast cancer
-
4:54
patient perspectives on t-dm1 vs paclitaxel/trastuzumab for her2 early breast cancer
-
3:01
bylieve additional cohort: update on the trial of alpelisib in advanced breast cancer from esmo
-
2:37
common breast cancer drug alpelisib may have an alarming side effect, finds study
-
5:54
the new t-dm1 breast cancer drug, an oncologist's reaction
-
5:57
alpelisib in the management of pik3ca-mutated breast cancer
-
1:55
benefit of antibody drug conjugate t-dm1 in her2 bc